197 related articles for article (PubMed ID: 25341723)
1. Circulating complement levels and C3 glomerulopathy.
Fervenza FC; Sethi S
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1829-31. PubMed ID: 25341723
[No Abstract] [Full Text] [Related]
2. Defining the complement biomarker profile of C3 glomerulopathy.
Zhang Y; Nester CM; Martin B; Skjoedt MO; Meyer NC; Shao D; Borsa N; Palarasah Y; Smith RJ
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1876-82. PubMed ID: 25341722
[TBL] [Abstract][Full Text] [Related]
3. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
Clardy CW; Forristal J; Strife CF; West CD
Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424
[TBL] [Abstract][Full Text] [Related]
4. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Iatropoulos P; Daina E; Curreri M; Piras R; Valoti E; Mele C; Bresin E; Gamba S; Alberti M; Breno M; Perna A; Bettoni S; Sabadini E; Murer L; Vivarelli M; Noris M; Remuzzi G; ;
J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
[TBL] [Abstract][Full Text] [Related]
5. C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
Wong EKS; Marchbank KJ; Lomax-Browne H; Pappworth IY; Denton H; Cooke K; Ward S; McLoughlin AC; Richardson G; Wilson V; Harris CL; Morgan BP; Hakobyan S; McAlinden P; Gale DP; Maxwell H; Christian M; Malcomson R; Goodship THJ; Marks SD; Pickering MC; Kavanagh D; Cook HT; Johnson SA;
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1639-1651. PubMed ID: 34551983
[TBL] [Abstract][Full Text] [Related]
6. Anti-Factor B Antibodies and Acute Postinfectious GN in Children.
Chauvet S; Berthaud R; Devriese M; Mignotet M; Vieira Martins P; Robe-Rybkine T; Miteva MA; Gyulkhandanyan A; Ryckewaert A; Louillet F; Merieau E; Mestrallet G; Rousset-Rouvière C; Thervet E; Hogan J; Ulinski T; Villoutreix BO; Roumenina L; Boyer O; Frémeaux-Bacchi V
J Am Soc Nephrol; 2020 Apr; 31(4):829-840. PubMed ID: 32034108
[TBL] [Abstract][Full Text] [Related]
7. Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritic factor and persistently low complement C3 and C5.
Hulton SA; Risdon RA; Dillon MJ
Pediatr Nephrol; 1992 May; 6(3):239-43. PubMed ID: 1616831
[TBL] [Abstract][Full Text] [Related]
8. Hypocomplementemia in a newborn infant caused by placental transfer of C3 nephritic factor.
Kim Y; Shvil Y; Michael AF
J Pediatr; 1978 Jan; 92(1):88-90. PubMed ID: 619090
[No Abstract] [Full Text] [Related]
9. Does nephritic factor relate to the disease activity in hypocomplementemic membranoproliferative glomerulonephritis?
Ohi H; Tanuma Y
Nephron; 1992; 62(1):116. PubMed ID: 1436279
[No Abstract] [Full Text] [Related]
10. High prevalence of hepatitis C virus antibodies in older patients with membranoproliferative glomerulonephritis.
Ohsawa I; Ohi H; Endo M; Fujita T; Seki M; Watanabe S
Nephron; 1999; 82(4):366-7. PubMed ID: 10450046
[No Abstract] [Full Text] [Related]
11. Complement activation in acute glomerulonephritis in children.
Levy M; Sich M; Pirotzky E; Habib R
Ric Clin Lab; 1980; 10(1):87-91. PubMed ID: 7008160
[No Abstract] [Full Text] [Related]
12. Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation.
Paixão-Cavalcante D; López-Trascasa M; Skattum L; Giclas PC; Goodship TH; de Córdoba SR; Truedsson L; Morgan BP; Harris CL
Kidney Int; 2012 Nov; 82(10):1084-92. PubMed ID: 22854646
[TBL] [Abstract][Full Text] [Related]
13. Loss of autoantibody activity by alteration in autoantigen.
Spitzer RE; Stitzel AE
Clin Immunol Immunopathol; 1996 Aug; 80(2):211-3. PubMed ID: 8764567
[TBL] [Abstract][Full Text] [Related]
14. Serum terminal complement component levels in hypocomplementemic glomerulonephritides.
Clardy CW; Forristal J; Strife CF; West CD
Clin Immunol Immunopathol; 1989 Mar; 50(3):307-20. PubMed ID: 2917423
[TBL] [Abstract][Full Text] [Related]
15. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
16. Hypocomplementaemia in a newborn caused by transplacental passage of maternal autoantibody with C3 nephritic factor (C3 NeF) activity.
Weiss L; Rougier N; Blouin J; Kazatchkine MD; Lhotta K; König P
Nephrol Dial Transplant; 1995 Dec; 10(12):2374. PubMed ID: 8808251
[No Abstract] [Full Text] [Related]
17. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
Geiger H; Good RA; Day NK
Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
[TBL] [Abstract][Full Text] [Related]
18. C3 metabolism in acute glomerulonephritis: implications for sites of complement activation.
Endre ZH; Pussell BA; Charlesworth JA; Coovadia HM; Seedat YK
Kidney Int; 1984 Jun; 25(6):937-41. PubMed ID: 6236326
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
Noris M; Donadelli R; Remuzzi G
Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
[TBL] [Abstract][Full Text] [Related]
20. C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy.
Garam N; Prohászka Z; Szilágyi Á; Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G; Bajcsi D; Brunner J; Dumfarth A; Cejka D; Flaschberger S; Flögelova H; Haris Á; Hartmann Á; Heilos A; Mueller T; Rusai K; Arbeiter K; Hofer J; Jakab D; Sinkó M; Szigeti E; Bereczki C; Janko V; Kelen K; Reusz GS; Szabó AJ; Klenk N; Kóbor K; Kojc N; Knechtelsdorfer M; Laganovic M; Lungu AC; Meglic A; Rus R; Kersnik-Levart T; Macioniene E; Miglinas M; Pawłowska A; Stompór T; Podracka L; Rudnicki M; Mayer G; Romana Rysava ; Reiterova J; Saraga M; Tomáš Seeman ; Zieg J; Sládková E; Szabó T; Capitanescu A; Stancu S; Tisljar M; Galesic K; Tislér A; Vainumäe I; Windpessl M; Zaoral T; Zlatanova G; Csuka D
Orphanet J Rare Dis; 2019 Nov; 14(1):247. PubMed ID: 31703608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
